ARCHIVES

FDA Spells Out Requirement For INDs For Cancer Drugs.

This article is from The Cancer Letter archive.

Vol. 28 No. 20 | May 17, 2002

Download PDF Visit The Full Archive

Related Articles

Symposium to Focus on New Approaches to Drug Resistance

May 11, 1990

IL-2 Trials Proliferate; Biotherapeutics Sees NCI Proposal As Vindication Of Its Policies

May 8, 1987

In Brief: FDA Cool To Committee Review of INDs; New Commissioner Is Donald Kennedy, Of Stanford

March 11, 1977

NIH Eyes FCRC For Intramural Space As Contract Recompetition Planning Nears

May 23, 1980

Okunieff To Lead SWOG Radiation Committee

July 19, 2002

More Workers Quit Smoking When Health Messages Combined

August 30, 2002